Has Mouhanad Freih, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,395 in general payments to Mouhanad Freih, MD across 584 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mouhanad Freih, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mouhanad Freih, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mouhanad Freih, MD

Cardiovascular Disease · Lewes, DENPI 1407979537

Payments from drug & device makers

$20,395in general payments, 2019–2025

Across 584 payments — averaging $34.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$7K
Boston Scientific$2K
Abbott$2K
AstraZeneca$869
Boehringer Ingelheim$773
Edwards Lifesciences$705
plus $8K from 48 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	164	$6,508
Boston Scientific	45	$2,281
Abbott	47	$1,751
AstraZeneca	47	$869
Boehringer Ingelheim	17	$773
Edwards Lifesciences	6	$705
Abiomed	16	$680
Cardiovascular Systems Inc.	12	$527
Heartflow, Inc.	13	$516
Amgen	23	$476
Pfizer	24	$453
E.r. Squibb & Sons, L.L.C.	13	$446
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	24	$440
Novartis	21	$428
Johnson & Johnson	15	$325
Philips North America LLC	6	$311
Novo Nordisk	15	$289
Inari Medical, Inc.	2	$263
Impulse Dynamics (USA) Inc.	2	$184
Esperion Therapeutics, Inc.	9	$158
Scpharmaceuticals Inc.	7	$144
Penumbra, Inc.	1	$141
Angiodynamics, Inc.	1	$134
Terumo Medical Corporation	1	$134
Roche Diagnostics Corporation	1	$118
Digirad Health, Inc	1	$116
Siemens Medical Solutions USA, Inc.	1	$110
ZOLL Respicardia, Inc.	1	$92
Bayer	4	$91
Lexicon Pharmaceuticals, Inc.	3	$89
Chiesi USA, Inc.	3	$65
Getinge USA Sales, LLC	2	$62
Biotronik Inc.	3	$61
Teleflex LLC	3	$59
Irhythm Technologies, Inc.	3	$57
Regeneron Healthcare Solutions, Inc.	3	$56
Kowa Pharmaceuticals America, Inc.	3	$44
Stryker	1	$38
Tactile Systems Technology Inc	2	$35
Lilly USA, LLC	2	$35
Azurity Pharmaceuticals, Inc.	1	$35
Lantheus Medical Imaging, Inc.	2	$33
Baxter Healthcare	2	$32
Bard Peripheral Vascular, Inc.	1	$31
Shockwave Medical, Inc	1	$29
Cardiva Medical, Inc.	1	$28
Medicomp Inc	1	$28
Amarin Pharma, Inc.	2	$26
GSK	1	$19
Merck	1	$18
Bridgebio Pharma, Inc.	1	$14
EKOS Corporation	1	$13
Lundbeck LLC	1	$13
Infobionic, Inc	1	$11

How this compares

$20,395 in reported general payments places this provider in the 80th percentile of 104 cardiovascular disease providers in Delaware.

See all cardiovascular disease providers in Delaware →

Medicare billing

Part B allowed, 2024

$1,217,124

Medicare patients

2,874

Services billed

13,408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Lewes

Rajinder PrasadLewes$72K
Ehtasham QureshiLewes$52K
Jude EdiaeLewes$13K
Ramon RosaLewes$12K
Kenneth SunnergrenLewes$11K
Gene MyersLewes$6K
Praveen GeorgeLewes$5K
Anthony ClayNewark$2.3M
William WeintraubNewark$1.3M
Vinay HosmaneWilmington$256K

See the full list for Delaware →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →